Showing results (411-420 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|March 31, 2025
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stentingHuai Wu Yuan, Xia Huang, Min Ying Pan, et al.
Pharmacogenomics|November 13, 2025
Pharmacogenetic markers of PEG-asparaginase toxicity in Brazilian pediatric ALL: insights from a multicenter prospective cohort studyDaiane Keller Cecconello, Klerize Anecely de Souza Silva, Evelin Cristine Mendonça de Senna, et al.
Pharmacogenomics|August 16, 2025
Genetic polymorphism associated with non-response to therapy in inflammatory bowel disease patients: a reviewThinagary Jegathesan, Syaratul Dalina Yusoff, Nor Asyikin Mohd Tahir
Pharmacogenomics|August 7, 2025
Pharmacogenetics of graft-versus-host disease: a path to personalized medicinePiotr Łacina, Jagoda Siemaszko, Katarzyna Bogunia-Kubik
Pharmacogenomics|September 15, 2025
A genome-wide association study of stroke risk in Asian statin users: evidence from KoGES and UK BiobankDa Hoon Lee, Yoon-A Park, Jung Sun Kim, et al.
Pharmacogenomics|September 13, 2013
Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case reportAnne-Pascale Laurenty, Fabienne Thomas, Etienne Chatelut, et al.
Pharmacogenomics|September 13, 2013
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosisCalliope A Dendrou, John I Bell, Lars Fugger
Pharmacogenomics|September 13, 2013
ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expressionTarek Magdy, Rudolf Arlanov, Stefan Winter, et al.
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Pharmacogenomics|September 13, 2013
Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolismHylke de Jonge, Henriette de Loor, Krisitin Verbeke, et al.
Pageof 274